Tate & Lyle (TATYY) Raised to Hold at Zacks Investment Research

Tate & Lyle (OTCMKTS:TATYY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports.

According to Zacks, “Tate & Lyle Ventures and Agri Investment Fund have co-led a 3.5m investment into Fugeia, a newly formed functional food technology business with a focus on gut health. “

Shares of TATYY stock opened at $39.06 on Friday. The company has a market cap of $4.78 billion, a price-to-earnings ratio of 14.68, a P/E/G ratio of 3.44 and a beta of 0.58. Tate & Lyle has a 52 week low of $32.49 and a 52 week high of $41.20.

Tate & Lyle Company Profile

Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products.

Further Reading: What are the FAANG Stocks?

Get a free copy of the Zacks research report on Tate & Lyle (TATYY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.